Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients
Published inAnnals of the rheumatic diseases, vol. 71, no. 6, p. 997-999
Publication date2012
Abstract
Keywords
- Adult
- Aged
- Antibodies, Monoclonal, Humanized/administration & dosage/pharmacokinetics
- Antirheumatic Agents/administration & dosage/pharmacokinetics
- Arthritis, Rheumatoid/drug therapy
- Female
- Glucocorticoids/administration & dosage/pharmacokinetics
- Humans
- Immunoconjugates/administration & dosage/pharmacokinetics
- Isoxazoles/administration & dosage/pharmacokinetics
- Male
- Methotrexate/administration & dosage/pharmacokinetics
- Middle Aged
- Prednisone/administration & dosage/pharmacokinetics
- Proportional Hazards Models
- Registries
- Remission Induction
- Treatment Outcome
- Tumor Necrosis Factor-alpha/antagonists & inhibitors
Affiliation entities
Research groups
Citation (ISO format)
MARTIN-DU-PAN, Sophie Marie Catherine et al. Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients. In: Annals of the rheumatic diseases, 2012, vol. 71, n° 6, p. 997–999. doi: 10.1136/annrheumdis-2011-200882
Main files (1)
Article (Published version)
Identifiers
- PID : unige:32505
- DOI : 10.1136/annrheumdis-2011-200882
- PMID : 22294628
Journal ISSN0003-4967
